FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

1488531000168102: South Australia reportable Schedule 4 medications reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Aug 2020. Module: Third party reference set module

Descriptions:

Id Description Lang Type Status Case? Module
4447321000168110 South Australia reportable Schedule 4 medications reference set (foundation metadata concept) en Fully specified name Active Case sensitive Third party reference set module
4462261000168117 South Australia reportable Schedule 4 medications reference set en Synonym Active Case sensitive Third party reference set module
4447341000168116 <p>Supports the identification of AMT MPUU, MPP, TPUU and CTPP concepts that are reportable within South Australia. </p><p>This reference set can be used by applications to identify reportable medications that are to be monitored for the <b>Script</b>Check<b>SA</b> real time prescription monitoring system requirements. Current reportable medicines are S4 medicines containing: </p><ul><li>Codeine </li><li>Gabapentin </li><li>Pregabalin </li><li>Quetiapine </li><li>Tramadol </li><li>Zolpidem </li><li>Zopiclone </li></ul><p>And benzodiazepines: </p><ul><li>Bromazepam </li><li>Chlordiazepoxide </li><li>Clobazam </li><li>Clonazepam </li><li>Clorazepate </li><li>Diazepam </li><li>Flurazepam </li><li>Ketazolam </li><li>Loprazolam </li><li>Lorazepam </li><li>Lormetazepam </li><li>Medazepam </li><li>Midazolam </li><li>Motrazepam </li><li>Nitrazepam </li><li>Oxazepam </li><li>Prazepam </li><li>Quazepam </li><li>Temazepam </li><li>Triazolam </li><li>Zolazepam </li></ul><p><b>Target client:</b> This reference set was developed by the National Clinical Terminology Service for SA Health, Government of South Australia, to support Real Time Reporting (RTR) of medications, and can be used by developers to assist with the requirements of the <b>Script</b>Check<b>SA</b> real time prescription monitoring system.</p><p><b>Labels:</b> RTPM, RTR, S4</p><p> </p><p> </p><p> </p> en Definition Active Case sensitive Third party reference set module


6598 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
South Australia reportable Schedule 4 medications reference set Is a Reference sets for Medications true Inferred relationship Some
South Australia reportable Schedule 4 medications reference set Is a Simple type reference set true Inferred relationship Some
South Australia reportable Schedule 4 medications reference set Developed by SA Health, Government of South Australia true Inferred relationship Some 1203581574

Members
Lyzalon 75 mg capsule, 56, bottle
Lyzalon 75 mg capsule, 60, blister pack
Lyzalon 75 mg capsule, 60, bottle
Lyzalon 75 mg capsule, 84, blister pack
Maxydol tablet
Maxydol tablet, 20, blister pack
Maxydol tablet, 40, blister pack
Mersyndol tablet
Mersyndol tablet, 20, blister pack
Mersyndol tablet, 40, blister pack
Mersyndol Caplet tablet
Mersyndol Caplet tablet, 2, blister pack
Mersyndol Caplet tablet, 20, blister pack
Mersyndol Caplet tablet, 40, blister pack
Mersyndol Daystrength tablet
Mersyndol Daystrength tablet, 12, blister pack
Mersyndol Daystrength tablet, 2, blister pack
Mersyndol Daystrength tablet, 24, blister pack
Mersyndol Daystrength tablet, 36, blister pack
Mersyndol Daystrength tablet, 40, blister pack
Mersyndol Daystrength tablet, 48, blister pack
Mersyndol Forte tablet
Mersyndol Forte tablet, 10, blister pack
Mersyndol Forte tablet, 2, blister pack
Mersyndol Forte tablet, 20, blister pack
Mersyndol Forte tablet, 40, blister pack
Mevadol Forte tablet
Mevadol Forte tablet, 20, blister pack
Midalim 15 mg/3 mL injection, 3 mL ampoule
Midalim 15 mg/3 mL injection, 10 x 3 mL ampoules
Midalim 15 mg/3 mL injection, 3 mL ampoule
Midalim 15 mg/3 mL injection, 5 x 3 mL ampoules
Midalim 5 mg/mL injection, ampoule
Midalim 5 mg/mL injection, 1 mL ampoule
Midalim 5 mg/mL injection, 10 x 1 mL ampoules
Midalim 5 mg/mL injection, 5 x 1 mL ampoules
Midalim (midazolam 5 mg / 5 mL) injection, 1 x 5 mL ampoule (containered trade product pack)
Midalim 5 mg/5 mL injection, 10 x 5 mL ampoules
Midalim 5 mg/5 mL injection, 5 mL ampoule
Midalim 5 mg/5 mL injection, 5 x 5 mL ampoules
Midalim (midazolam 50 mg / 10 mL) injection, 1 x 10 mL ampoule (containered trade product pack)
Midalim 50 mg/10 mL injection, 10 mL ampoule
Midalim 50 mg/10 mL injection, 10 x 10 mL ampoules
Midalim 50 mg/10 mL injection, 5 x 10 mL ampoules
Midavel 15 mg/3 mL injection, 3 mL ampoule
Midavel 15 mg/3 mL injection, 10 x 3 mL ampoules
Midavel 15 mg/3 mL injection, 3 mL ampoule
Midavel 15 mg/3 mL injection, 5 x 3 mL ampoules
Midavel 5 mg/mL injection, ampoule
Midavel 5 mg/mL injection, 1 mL ampoule
Midavel 5 mg/mL injection, 10 x 1 mL ampoules
Midavel (midazolam 5 mg / 1 mL) injection, 5 x 1 mL ampoules (containered trade product pack)
Midavel 5 mg/5 mL injection, 5 mL ampoule
Midavel 5 mg/5 mL injection, 10 x 5 mL ampoules
Midavel 5 mg/5 mL injection, 5 mL ampoule
Midavel 5 mg/5 mL injection, 5 x 5 mL ampoules
Midavel 50 mg/10 mL injection, 10 mL ampoule
Midavel 50 mg/10 mL injection, 10 mL ampoule
Midavel 50 mg/10 mL injection, 10 x 10 mL ampoules
Midavel 50 mg/10 mL injection, 5 x 10 mL ampoules
Midazolam (AN) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (AN) 15 mg/3 mL injection, 10 x 3 mL ampoules
Midazolam (AN) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (AN) 15 mg/3 mL injection, 5 x 3 mL ampoules
Midazolam (AN) 5 mg/mL injection, ampoule
Midazolam (AN) 5 mg/mL injection, 1 mL ampoule
Midazolam (AN) 5 mg/mL injection, 10 x 1 mL ampoules
Midazolam (AN) 5 mg/mL injection, 5 x 1 mL ampoules
Midazolam (AN) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (AN) 5 mg/5 mL injection, 10 x 5 mL ampoules
Midazolam (AN) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (AN) 5 mg/5 mL injection, 5 x 5 mL ampoules
Midazolam (AN) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (AN) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (AN) 50 mg/10 mL injection, 10 x 10 mL ampoules
Midazolam (AN) 50 mg/10 mL injection, 5 x 10 mL ampoules
Midazolam (Accord) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Accord) 15 mg/3 mL injection, 10 x 3 mL ampoules
Midazolam (Accord) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Accord) 15 mg/3 mL injection, 5 x 3 mL ampoules
Midazolam (Accord) 5 mg/mL injection, ampoule
Midazolam (Accord) 5 mg/mL injection, 1 mL ampoule
Midazolam (Accord) 5 mg/mL injection, 10 x 1 mL ampoules
Midazolam (Accord) 5 mg/mL injection, 5 x 1 mL ampoules
Midazolam (Accord) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (Accord) 5 mg/5 mL injection, 1 x 5 mL syringe
Midazolam (Accord) 5 mg/5 mL injection, 10 x 5 mL ampoules
Midazolam (Accord) 5 mg/5 mL injection, 5 mL ampoule
Midazolam (Accord) 5 mg/5 mL injection, 5 mL syringe
Midazolam (Accord) 5 mg/5 mL injection, 5 x 5 mL ampoules
Midazolam (Accord) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (Accord) 50 mg/10 mL injection, 1 x 10 mL syringe
Midazolam (Accord) 50 mg/10 mL injection, 10 mL ampoule
Midazolam (Accord) 50 mg/10 mL injection, 10 mL syringe
Midazolam (Accord) 50 mg/10 mL injection, 10 x 10 mL ampoules
Midazolam (Accord) 50 mg/10 mL injection, 5 x 10 mL ampoules
Midazolam (Act) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Act) 15 mg/3 mL injection, 10 x 3 mL ampoules
Midazolam (Act) 15 mg/3 mL injection, 3 mL ampoule
Midazolam (Act) (midazolam 15 mg / 3 mL) injection, 5 x 3 mL ampoules (containered trade product pack)
Midazolam (Act) 5 mg/mL injection, ampoule

Start Previous Page 21 of 66 Next End


Reference Sets

Reference set descriptor

Back to Start